Yuan Lingling, Wang Yingyi, Li Na, Yang Xuli, Sun Xuhui, Tian Huai'e, Zhang Yi
Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Department of Infection, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Antioxidants (Basel). 2024 Aug 20;13(8):1012. doi: 10.3390/antiox13081012.
Oxidative stress (OS) is a key factor in the generation of various pathophysiological conditions. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) is a major transcriptional regulator of antioxidant reactions. Heme oxygenase-1 (HO-1), a gene regulated by Nrf2, is one of the most critical cytoprotective molecules. In recent years, Nrf2/HO-1 has received widespread attention as a major regulatory pathway for intracellular defense against oxidative stress. It is considered as a potential target for the treatment of inflammatory bowel disease (IBD). This review highlights the mechanism of action and therapeutic significance of Nrf2/HO-1 in IBD and IBD complications (intestinal fibrosis and colorectal cancer (CRC)), as well as the potential of phytochemicals targeting Nrf2/HO-1 in the treatment of IBD. The results suggest that the therapeutic effects of Nrf2/HO-1 on IBD mainly involve the following aspects: (1) Controlling of oxidative stress to reduce intestinal inflammation and injury; (2) Regulation of intestinal flora to repair the intestinal mucosal barrier; and (3) Prevention of ferroptosis in intestinal epithelial cells. However, due to the complex role of Nrf2/HO-1, a more nuanced understanding of the exact mechanisms involved in Nrf2/HO-1 is the way forward for the treatment of IBD in the future.
氧化应激(OS)是多种病理生理状况产生的关键因素。核因子红细胞2(NF-E2)相关因子2(Nrf2)是抗氧化反应的主要转录调节因子。血红素加氧酶-1(HO-1)是一种受Nrf2调控的基因,是最关键的细胞保护分子之一。近年来,Nrf2/HO-1作为细胞内抵御氧化应激的主要调节途径受到广泛关注。它被认为是治疗炎症性肠病(IBD)的潜在靶点。本综述重点介绍了Nrf2/HO-1在IBD及其并发症(肠道纤维化和结直肠癌(CRC))中的作用机制和治疗意义,以及靶向Nrf2/HO-1的植物化学物质在IBD治疗中的潜力。结果表明,Nrf2/HO-1对IBD的治疗作用主要涉及以下几个方面:(1)控制氧化应激以减轻肠道炎症和损伤;(2)调节肠道菌群以修复肠道黏膜屏障;(3)预防肠道上皮细胞铁死亡。然而,由于Nrf2/HO-1的作用复杂,更细致地了解Nrf2/HO-1的确切机制是未来IBD治疗的前进方向。